Celltrions tocilizumab biosimilar, tocilizumab-anoh (Avtozma, CT-P47), had similar efficacy when switching from reference tocilizumab (Actemra; Genentech) in a study of 444 RA patients x 52 wks. https://t.co/7aAyuUkZJ9 https://t.co/kJUrRkhstb
Links:
Efficacy and Safety of Biosimilar CT-P47 Versus Reference Tocilizumab: 1-Year R…
https://buff.ly/QDOMmnP
26-08-2025
